Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC as identified by liquid (LBx) or tissue (TBx) biopsy Meeting Abstract


Authors: Felip, E.; Garassino, M. C.; Sakai, H.; Le, X.; Veillon, R.; Smit, E.; Mazieres, J.; Cortot, A.; Raskin, J.; Thomas, M.; Viteri, S.; Iams, W.; Kim, H. R.; Yang, J.; Stroh, C.; Otto, G.; Bruns, R.; Paik, P.
Abstract Title: Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC as identified by liquid (LBx) or tissue (TBx) biopsy
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: met inhibitor
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S1085
End Page: S1086
Language: English
ACCESSION: WOS:000709606500470
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.471
Notes: Meeting Abstract: P45.03 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik